tiprankstipranks
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Hong Kong Market
2367
Giant Biogene Holding Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:2367 full AI Analyst Report?

Giant Biogene Holding Co. Ltd. (2367) Financial Statements

11 Followers

Giant Biogene Holding Co. Ltd. Financial Overview

Giant Biogene Holding Co. Ltd.'s market cap is currently HK$32.60B. The company's EPS TTM is HK$1.81; its P/E ratio is 11.11; and it has a dividend yield of 1.84%. Giant Biogene Holding Co. Ltd. is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is HK$1.20. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 5.38B¥ 5.54B¥ 3.52B¥ 2.36B¥ 1.55B
Gross Profit¥ 4.32B¥ 4.55B¥ 2.95B¥ 2.00B¥ 1.35B
Operating Income¥ 2.06B¥ 2.31B¥ 1.66B¥ 1.13B¥ 914.57M
EBITDA¥ 2.14B¥ 2.31B¥ 1.78B¥ 1.21B¥ 933.64M
Net Income¥ 1.87B¥ 2.06B¥ 1.45B¥ 1.00B¥ 828.13M
Balance Sheet
Cash & Short-Term Investments¥ 8.29B¥ 5.86B¥ 3.78B¥ 2.20B¥ 7.26B
Total Assets¥ 10.85B¥ 8.04B¥ 4.97B¥ 3.14B¥ 7.88B
Total Debt¥ 9.69M¥ 6.71M¥ 2.73M¥ 2.59M¥ 0.00
Net Debt¥ -6.30B¥ -4.02B¥ -2.50B¥ -1.33B¥ -7.10B
Total Liabilities¥ 917.03M¥ 918.14M¥ 602.03M¥ 301.19M¥ 6.86B
Stockholders' Equity¥ 9.92B¥ 7.11B¥ 4.36B¥ 2.83B¥ 1.02B
Cash Flow
Free Cash Flow¥ 1.48B¥ 1.79B¥ 1.42B¥ 778.39M¥ 581.21M
Operating Cash Flow¥ 1.90B¥ 2.04B¥ 1.65B¥ 931.64M¥ 692.40M
Investing Cash Flow¥ -471.99M¥ -1.11B¥ -527.28M¥ -858.74M¥ 1.56B
Financing Cash Flow¥ 892.40M¥ 582.95M¥ 51.81M¥ -5.79B¥ 4.48B
Currency in CNY

Giant Biogene Holding Co. Ltd. Earnings and Revenue History

Income Statement >

Giant Biogene Holding Co. Ltd. Debt to Assets

Balance Sheet >

Giant Biogene Holding Co. Ltd. Cash Flow

Cash Flow >

Giant Biogene Holding Co. Ltd. Forecast EPS vs Actual EPS

Earnings >